A detailed history of Nexus Investment Management Ulc transactions in Eli Lilly & CO stock. As of the latest transaction made, Nexus Investment Management Ulc holds 809 shares of LLY stock, worth $741,950. This represents 0.07% of its overall portfolio holdings.

Number of Shares
809
Previous 826 2.06%
Holding current value
$741,950
Previous $747,000 4.15%
% of portfolio
0.07%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $13,126 - $16,320
-17 Reduced 2.06%
809 $716,000
Q4 2022

Jan 09, 2023

BUY
$321.55 - $374.67 $265,600 - $309,477
826 New
826 $302,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $871B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nexus Investment Management Ulc Portfolio

Follow Nexus Investment Management Ulc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nexus Investment Management Ulc, based on Form 13F filings with the SEC.

News

Stay updated on Nexus Investment Management Ulc with notifications on news.